Comparative study of survivor and nonsurvivor sepsis patients in a university hospital

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 1, 2008, Pages 50-54

  De Oliveira, Aline Pâmela Vieira ^a   Barata, Cristina Hueb ^a   Murta, Eddie Fernando Candido ^a   Tavares Murta, Beatriz Martins ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Antimicrobials; Prognosis; Risk factors; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; EVALUATION; EVIDENCE BASED PRACTICE; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SURVIVOR; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SURVIVAL ANALYSIS;

POSIBACTERIA;

EID: 41549153860     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000100010     Document Type: Article

References (27)

1. Adrie C, Alberti C, Chaix-Couturier C, Azoulay E, Lassence A, Cohen Y, Meshaka P, Cheval C, Thuong M, Troché G, Garrouste-Orgeas M, Timsit J-F. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinant of workload and cost. Journal of Critical Care 20: 46-58, 2005.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome and associated costs of care. Critical Care Medicine 29: 1303-1310, 2001.
3. Angus DC, Wax RS. Epidemiology of sepsis: An update. Critical Care Medicine 29: 109-116, 2001.
4. Arraes SM, Freitas MS, Silva SV, Paula Neto H, Alves-Filho JC, Martins MA, Basile-Filho A, Tavares-Murta BM, Barja-Fidalgo C, Cunha FQ. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 108: 2906-2913, 2006.
5. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Critical Care Medicine 20: 864-874, 1992.
6. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet 368: 157-169, 2006.
7. Cohen J. The immunopathogenesis of sepsis. Nature 420: 885-891, 2002.
8. Cohen J, Cristofaro P, Carlet J, Opal S. New method of classifying infections in critically ill patients. Critical Care Medicine 32: 1510-1526, 2004.
9. Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG. Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. Journal of the American Medical Association 282: 2143-2148, 1999.
10. De Miguel-Yanes JM, Andueza-Lillo JA, Gonzalez-Ramallo VJ, Pastor L, Munoz J. Failure to implement evidence-based clinical guidelines for sepsis at the ED. American Journal of Emergency Medicine 24: 553-559, 2006.
11. Dhainaut JF, Claessens YE, Janes J, Nelson DR. Underlying disorders and their impact on the host response to infection. Clinical Infectious Diseases 41: 481-489, 2005.
12. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: Factors that influence disparities in sepsis. Critical Care Medicine 34: 2576-2582, 2006.
13. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar AF, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empiric antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Critical Care Medicine 31: 2742-2751, 2003.
14. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. American Journal of Medicine 115: 529-535, 2003.
15. Jacobson S, Johansson G, Winso O. Primary sepsis in a university hospital in northern Sweden: A retrospective study. Acta Anaesthesiologica Scandinavica 48: 960-967, 2004.
16. Malawista SE, Montgomery RR, van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes. Journal of Clinical Investigation 90: 631-636, 1992.
17. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 348: 1546-1554, 2003.
18. Mendonça MAO, Cunha FQ, Murta EFC, Tavares-Murta BM. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy. Cancer Chemotherapy and Pharmacology 57: 663-670, 2006.
19. Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends in Immunology 25: 75-84, 2004.
20. Poeze M, Ramsay G, Gerlach H, Rubulotta F, Levy M. An international sepsis survey: a study of doctor's knowledge and perception about sepsis. Critical Care 8: 409-413, 2004
21. Riedemann NC, Guo R-F, Ward PA. The enigma of sepsis. Journal of Clinical Investigation 112: 460-467, 2003.
22. Sarkar P, Gould IM. Antimicrobial agents are societal drugs: how should this influence prescribing? Drugs 66: 893-901, 2006.
23. Strehlow MC, Emond SD, Shapiro NI, Pelletier AJ, Camargo Jr CA. National study of emergency department visits for sepsis. Annals of Emergency Medicine 48: 326-331, 2006.
24. Tavares-Murta BM, Zaparolli M, Ferreira RB, Silva-Vergara ML, Oliveira CHB, Murta EFC, Ferreira SH, Cunha FQ. Failure of neutrophil chemotactic function in septic patients. Critical Care Medicine 30: 1056-1061, 2002.
25. Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21: 215-226, 2004.
26. Velasco E, Byington R, Martins CAS, Schirmer M, Dias LMC, Gonçalves VMSC. Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. European Journal of Clinical Microbiology & Infectious Diseases 25: 1-7, 2006.
27. Xiao H, Siddiqui J, Remick DG. Mechanisms of mortality in early and late sepsis. Infection and Immunity 74: 5227-5235, 2006.